Bold Line Graph Sheets: 0.25 Inch Squares
by American Printing House for the Blind
Last verified June 15, 2026 · classified May 14, 2026
What it is
Summary
AI-generated from vendor-published content · May 14, 2026
These are standard 8.5×11 graph sheets printed with high-contrast bold lines — thick unit lines and thinner sub-unit lines — sized at 0.25-inch squares. They're designed for students with low vision who need to do graphing, math, or science work but can't easily track standard light-gray grid lines. This is a consumable supply item: a pack of paper sheets, not a device. The bold line format reduces the visual clutter that makes ordinary graph paper inaccessible, without requiring any special equipment. Students who benefit from high-contrast materials in general will find these more usable than commercial graph paper, but the 0.25-inch squares may be too small for those who also need larger print or have significant fine motor challenges — APH also offers larger-square and tactile graph sheet options for those needs.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Open the package and use the sheets with standard pencil or dark felt-tip pen for best contrast.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on May 14, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.